Ahmedabad: Zydus Lifesciences Limited has announced that it has received in principle acceptability from World Health ...

Zydus Lifesciences' ZyVac TCV typhoid vaccine receives WHO prequalification, opening doors for UN procurement programs in ...

Zydus Lifesciences' shares rose 2.81% after receiving WHO approval for its indigenously developed typhoid vaccine, ZyVac TCV, ...

Zydus Lifesciences' ZyVac TCV receives WHO prequalification, eligible for U.N. procurement, combating typhoid fever in ...

Indian multinational pharmaceutical company Zydus Lifesciences Ltd on Wednesday announced that its Typhoid Vi conjugate ...

As per GAVI (2022) it is estimated that Typhoid accounts for an estimated 11 to 21 million cases of febrile illness and ...

Zydus Wellness launches Sugar Free D’lite cookies with Bollywood superstar Shahid Kapoor endorsing the product. The brand ...

Consumer wellness company Zydus Wellness has ventured into packaged foods segment with Sugar Free D’lite cookies and ...

Zydus Lifesciences advanced 1.71% to Rs 1,005.05 after the company received in principle acceptability from World Health Organisation (WHO) for its ZyVac TCV vaccine.

Zydus Lifesciences Ltd has received approval from the WHO for its Typhoid conjugate vaccine, ZyVac TCV, to be procured by United Nations agencies. Developed in Ahmedabad, it targets ages 6 months to ...

From what is understood, as a part of the collaboration, Kapoor took to his social media handle to promote a healthy ...

Zydus Lifesciences's Typhoid Vi conjugate vaccine, ZyVac TCV, has received WHO prequalification, making it eligible for UN ...